Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  ImmunoPrecise Antibodies Ltd.    IPA   CA45257F2008

IMMUNOPRECISE ANTIBODIES LTD.

(IPA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The tendency within the weekly time frame is positive above the technical support level at 8.35 CAD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
Sector Biopharmaceuticals
1st jan.Capitalisation (M$)Investor Rating
IMMUNOPRECISE ANTIBODIES LT..3.40%268
-
CSL LIMITED-2.70%96 233
SAMSUNG BIOLOGICS CO.,LTD.-4.36%50 715
BIOGEN INC.8.29%40 802
CHONGQING ZHIFEI BIOLOGICAL..12.91%40 785
ALEXION PHARMACEUTICALS, IN..3.53%34 072
CELLTRION HEALTHCARE CO LTD--.--%21 101
UCB2.34%19 760
GRIFOLS, S.A.5.86%17 770
INNOVENT BIOLOGICS, INC.21.88%17 247
SHENZHEN KANGTAI BIOLOGICAL..-2.01%17 130
BIOMARIN PHARMACEUTICAL INC..-5.19%15 111
ZAI LAB LIMITED15.97%13 816
BLOE BIOT0.00%13 698
SHANGHAI JUNSHI BIOSCIENCES..58.45%11 308
CANSINO BIOLOGICS INC.63.29%11 070
-
More Results
Financials
Sales 2021 20,4 M 15,8 M 15,8 M
Net income 2021 -2,59 M -2,01 M -2,01 M
Net Debt 2021 - - -
P/E ratio 2021 -144x
Yield 2021 -
Capitalization 342 M 268 M 266 M
Capi. / Sales 2021 16,8x
Capi. / Sales 2022 15,1x
Nbr of Employees -
Free-Float 92,4%
Upcoming event on IMMUNOPRECISE ANTIBODIES LTD.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality -
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes